Stockreport

NeuroSense Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF novel treatments for severe neurodegenerative diseases, today announced it has entered into a securities purchase agreement with a single health-care focused institution [Read more]